TRT side effects: does the black market really cause most problems?

What did @mytrt.health actually say?

Here is the problem: the transcript provided does not match the video caption at all. The auto-generated transcript appears to be a garbled, AI-mistranscribed block of unrelated English filler text about parents visiting and battery-powered devices. It bears no relationship to the German-language caption, which makes claims about black market testosterone causing "inflammations, abscesses, and hormone chaos" while bodybuilder dosing advice can "ruin you more than help."

So we are fact-checking the caption, because that is what the audience actually reads. The creator's central argument appears to be: side effects on TRT are largely a product of bad sourcing or bad protocols, not TRT itself. That is a specific, testable claim, and it deserves a real answer.

Does the science back this up?

Partially, yes. The link between unregulated testosterone products and injection-site complications is well-documented. A 2019 paper by Grech et al. in Clinical Endocrinology reviewed adverse events in men using unsupervised anabolic-androgenic steroids and found injection-site abscess rates dramatically higher than in clinical populations using pharmaceutical-grade products under medical supervision.

The contamination concern is also legitimate. A 2014 analysis published in Drug Testing and Analysis (Van der Merwe et al.) found that a significant proportion of black-market anabolic steroid products were either mislabeled, contaminated with other compounds, or contained doses wildly different from the label. That creates unpredictable hormone levels, which can produce estrogenic side effects, erratic mood, and suppression of natural testosterone production at unanticipated rates.

So the caption's framing is mostly grounded in real pharmacological risk. Where it gets slippery is the implicit suggestion that medically supervised TRT is side-effect-free if done correctly. It is not.

What did they get wrong (or right)?

They got the black-market risk framing right. That is not a trivial point worth dismissing. Patients who self-source testosterone face real, documented harms that go beyond what regulated clinical TRT produces.

But the claim that side effects are primarily caused by doing it "wrong" is oversimplified to the point of being misleading. Even properly dosed, pharmaceutical-grade testosterone therapy carries real risks: polycythemia (elevated red blood cell count), suppression of spermatogenesis, cardiovascular signal concerns, and testicular atrophy. These occur in supervised clinical settings with verified products. A 2023 meta-analysis by Lincoff et al. in The New England Journal of Medicine (the TRAVERSE trial) found a statistically significant increase in non-fatal cardiovascular events in testosterone-treated men compared to placebo, at doses well within clinical norms.

The "bodybuilder tips can ruin you" line is broadly accurate, particularly regarding supraphysiological dosing strategies common in performance-enhancement communities that use testosterone at 5 to 10 times replacement doses. Those protocols are categorically different from clinical TRT and should not be conflated.

What should you actually know?

If you are considering testosterone therapy, the source and the supervision both matter, but supervised therapy is not a guarantee of zero side effects. Here is what the evidence actually supports:

• Black-market testosterone products carry real contamination and misdosing risks documented in pharmaceutical quality-control literature. This is not fearmongering.
• Clinical TRT, done through a licensed provider with baseline bloodwork and ongoing monitoring, substantially reduces but does not eliminate cardiovascular and hematological risks.
• The TRAVERSE trial (Lincoff et al., 2023, NEJM) is the largest randomized trial of testosterone therapy in men with hypogonadism. It showed a modest but real increase in cardiovascular event risk. Any provider who tells you supervised TRT has no cardiac risk is not being straight with you.
• Erythrocytosis (hematocrit above 54%) is one of the most common side effects in clinical TRT populations and requires monitoring, typically every three to six months in stable patients, per Endocrine Society guidelines.
• Bodybuilder-style dosing is not TRT. Framing them as versions of the same thing distorts both the risk profile and the intended use case.

The bottom line on this video's claims

The creator is making a marketing argument dressed as a harm-reduction argument. That does not make the underlying facts wrong, but it does mean you should read the framing critically. Yes, black-market sourcing is genuinely dangerous. Yes, unsupervised high-dose protocols carry risks that supervised replacement dosing typically does not. But TRT through a telehealth platform is not risk-free, and a video that attributes nearly all TRT side effects to bad sourcing or bad protocol is leaving out the portion of the clinical literature that is inconvenient for that argument.

Give them credit for the black-market warning. Push back on the implicit claim that proper medical TRT is essentially consequence-free if managed correctly.